MedPath

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

Recruiting
Conditions
Biliary Tract Cancer
Liver Cancer
Pancreatic Cancer
Registration Number
NCT06139042
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

LIBRARY is a prospective, multi-center, observational study aimed at detecting early liver, biliary tract, and pancreatic cancers by combining assays of cell-free DNA (cfDNA) methylation, serum protein, and microRNA.

Detailed Description

LIBRARY is a prospective, multi-center, observational study aimed at detecting early liver, biliary tract, and pancreatic cancers by combining assays of cell-free DNA (cfDNA) methylation, serum protein, and microRNA. The study will enroll approximately 458 participants diagnosed with liver, biliary tract, and pancreatic cancers, 330 individuals with corresponding benign diseases and 820 healthy participants.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1608
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The sensitivity and specificity of the cfDNA methylation model in detection of liver, biliary tract and pancreatic cancers.24 months
Secondary Outcome Measures
NameTimeMethod
The sensitivity and specificity of the combined model in detection of different subtypes of cancers.24 months
The sensitivity and specificity of the combined model in detection of different stages of liver, biliary tract and pancreatic cancers.24 months

Trial Locations

Locations (1)

The Second Affiliated Hospital, Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

The Second Affiliated Hospital, Zhejiang University School of Medicine
🇨🇳Hangzhou, Zhejiang, China
Weilin Wang, M.D.
Contact
+8657187783820
wam@zju.edu.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.